Soleno Shaken By FDA Demand For Second DCCR Phase III Trial In PWS

The Biotech Adequately Funded So Likely To Comply

 
• By Sten Stovall
  
Clinical Trial
Additional controlled clinical trial needed to support an NDA submission

More from Clinical Trials

More from R&D